03770024131079 3770024131INF-ADAX3 mAbXmise IADA1 mAbXmise – Anti-drug antibodies quantification Kit multiplex ANTI-Infliximab & ANTI-Adalimumab Promise proteomics FR-MF-000027377 IVD Sınıf B IVDR 2017/746 W01020899 THERAPEUTIC DRUG MONITORING - OTHER Piyasada IADA1 France 2026-07-30T18:57:44.364Z 03770024131055 3770024131PNH-TDM7A mAbXmise PNHTDM mAbXmise – Monoclonal antibodies quantification Kit Eculizumab or Ravulizumab Promise proteomics FR-MF-000027377 IVD Sınıf B IVDR 2017/746 W01020899 THERAPEUTIC DRUG MONITORING - OTHER Piyasada PNHTDM France 2026-07-30T18:57:43.579Z 03770024131048 3770024131HEM-TDMYZ mAbXmise HTDM mAbXmise – Monoclonal antibody quantification Kit Emicizumab Promise proteomics FR-MF-000027377 IVD Sınıf B IVDR 2017/746 W01020899 THERAPEUTIC DRUG MONITORING - OTHER Piyasada HTDM France 2026-07-30T18:57:42.760Z 03770024131000 3770024131INF-TDM2V mAbXmise ITDM2 mAbXmise – Monoclonal antibodies quantification Kit Multiplex Infliximab, Adalimumab, Obinutuzumab, Secukinumab, Tocilizumab, Ustekinumab, Vedolizumab Promise proteomics FR-MF-000027377 IVD Sınıf B IVDR 2017/746 W0102080701 INFLIXIMAB Piyasada ITDM2 France 2026-07-30T18:57:41.960Z 03770024131031 B-03770024131031 mAbXmise GTDM mAbXmise – Quantification kit Belatacept or Abatacept Promise proteomics FR-MF-000027377 IVD Genel IVDD W01020899 THERAPEUTIC DRUG MONITORING - OTHER Piyasada GTDM France 2026-07-19T17:47:33.748Z 03770024131024 B-03770024131024 mAbXmise OTDM1 mAbXmise – Monoclonal antibodies quantification Kit Multiplex Nivolumab, Pembrolizumab, Trastuzumab, Cetuximab, Bevacizumab, Ipilimumab, Rituximab Promise proteomics FR-MF-000027377 IVD Genel IVDD W0102080704 RITUXIMAB Piyasada OTDM1 France 2026-07-19T17:47:32.948Z 03770024131017 B-03770024131017 mAbXmise ITDM1 mAbXmise – Monoclonal antibodies quantification Kit Multiplex Infliximab & Adalimumab Promise proteomics FR-MF-000027377 IVD Genel IVDD W0102080701 INFLIXIMAB Piyasada ITDM1 France 2026-07-19T17:47:32.147Z